Generic Drug Reform Outlook: Medicare Rx Bill May Be Best Vehicle
Executive Summary
The best opportunity to push Waxman/Hatch reforms in the next Congress will likely be in the context of a Medicare prescription drug benefit bill
You may also be interested in...
Senate GOP Victories Leave Frist As First Among Equals On Health Issues
The Senate Finance Committee would add a staunch supporter of a private competition-based prescription drug program under Medicare if Sen. Bill Frist (R-Tenn.) is appointed to the committee
Senate Change Puts Hatch, Gregg, Grassley In Line For Key Rx Committees
The transfer of control in the Senate puts Sen. Orrin Hatch (R-Utah) in position to have greater influence in guiding generic drug reform legislation
Rx Pricing Attacks Fail In Key House Races; Medicare Rx Vote Protects GOP
The House leadership is unlikely to change its approach to Medicare prescription drug coverage and pharmaceutical pricing following the Republican victories in the mid-term elections Nov. 5